Blocking the Self-Destruct Program of Dopamine Neurons

Movement Disorders, 2024

This translational study highlights a new therapeutic target for Parkinson’s disease: inhibiting the nuclease activity of macrophage migration inhibitory factor (MIF). By blocking this “executioner” enzyme, the authors show protection of dopamine neurons from self-destruction.

Previous
Previous

Lewy Body Dementia Promotion by Air Pollutants

Next
Next

Parthanatos: Mechanisms, Modulation, and Therapeutic Prospects